Cargando…

An Insight Into Intestinal Microbiota of Spontaneously Hypertensive Rats After Valsartan Administration

It has been proven a close relationship between intestinal microbiota and hypertension. Valsartan is a widely used ARB antihypertensive drug; so far, the effect of valsartan on intestinal microbiota remains largely unexplored. Herein, we evaluated the composition, structure and metabolites of intest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Ying-Zi, Jiang, Yue-Hua, Jiang, Ling-Yu, Shao, Lin-Lin, Yang, Xue-Song, Yang, Chuan-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113937/ https://www.ncbi.nlm.nih.gov/pubmed/33994888 http://dx.doi.org/10.1177/15593258211011342

Ejemplares similares

Study of the Mechanism Underlying the Antihypertensive Effects of Eucommia ulmoides and Tribulus terrestris Based on an Analysis of the Intestinal Microbiota and Metabonomics
por: Qi, Ying-Zi, et al.
Publicado: (2020)

Integrated analysis of long noncoding RNA and mRNA profiling ox-LDL-induced endothelial dysfunction after atorvastatin administration
por: Jiang, Ling-Yu, et al.
Publicado: (2018)

Reverse electromechanical modelling of diastolic dysfunction in spontaneous hypertensive rat after sacubitril/valsartan therapy
por: Sung, Yen‐Ling, et al.
Publicado: (2020)

Valsartan Decreases Platelet Activity and Arterial Thrombotic Events in Elderly Patients with Hypertension
por: Wu, Fang, et al.
Publicado: (2015)

Sacubitril/Valsartan Improves Sexual Function and Fibrosis of the Clitoral and Vaginal Tissues in Female Spontaneously Hypertensive Rats
por: Zhuang, Chenchen, et al.
Publicado: (2022)

Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats
por: Takai, Shinji, et al.
Publicado: (2013)

Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?
por: CHEN, Yang, et al.
Publicado: (2020)

Enhanced Protective Effect of the Combination of Uncaria and Semen Raphani on Vascular Endothelium in Spontaneously Hypertensive Rats
por: Li, Yun-lun, et al.
Publicado: (2015)

Study on the Mechanism of Bu-Shen-He-Mai Granules in Improving Renal Damage of Ageing Spontaneously Hypertensive Rats by Regulating Th17 Cell/Tregs Balance
por: Zhang, Peng, et al.
Publicado: (2022)

Administration with Quinoa Protein Reduces the Blood Pressure in Spontaneously Hypertensive Rats and Modifies the Fecal Microbiota
por: Guo, Huimin, et al.
Publicado: (2021)

Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023)

Comparison of the Ameliorating Effects of Valsartan and Amlodipine on Vascular Endothelial Dysfunction and Oxidative Stress in Elderly Patients with Type H Hypertension
por: Zhang, Lijuan, et al.
Publicado: (2022)

Elevated expression of periostin in diabetic cardiomyopathy and the effect of valsartan
por: Guan, Jun, et al.
Publicado: (2015)

Effects of Sacubitril/Valsartan on resistant hypertension and myocardial work in hemodialysis patients
por: Wang, Bin, et al.
Publicado: (2022)

The Difference between Sacubitril Valsartan and Valsartan on Vascular Endothelial Function, APN, MMP-9, and BNP Levels in Patients with Hypertension and Chronic Heart Failure
por: Du, Haiping, et al.
Publicado: (2022)

The efficacy and safety of Sacubitril/Valsartan on pulmonary hypertension in hemodialysis patients
por: Zhao, Cong, et al.
Publicado: (2022)

Angiotensin II Receptor–Neprilysin Inhibitor Sacubitril/Valsartan Improves Endothelial Dysfunction in Spontaneously Hypertensive Rats
por: Seki, Takunori, et al.
Publicado: (2017)

Aliskiren and valsartan combination therapy for the management of hypertension
por: Epstein, Benjamin J
Publicado: (2010)

The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure
por: Xu, Yu, et al.
Publicado: (2023)

Effects of Losartan, Atorvastatin, and Aspirin on Blood Pressure and Gut Microbiota in Spontaneously Hypertensive Rats
por: Dong, Shuai, et al.
Publicado: (2023)

Insights into implementation of sacubitril/valsartan into clinical practice
por: Martens, Pieter, et al.
Publicado: (2018)

Differential Analysis of Hypertension-Associated Intestinal Microbiota
por: Dan, Xie, et al.
Publicado: (2019)

Differential Analysis of Hypertension-Associated Intestinal Microbiota
por: Dan, Xie, et al.
Publicado: (2021)

Efficacy and Safety of Valsartan or Chlorthalidone vs. Combined Valsartan and Chlorthalidone in Patients With Mild to Moderate Hypertension: The VACLOR Study
por: Manzur, Fernando, et al.
Publicado: (2018)

Clinical utility of valsartan in the treatment of hypertension in children and adolescents
por: Baracco, Rossana, et al.
Publicado: (2011)

Time of administration important? Morning versus evening dosing of valsartan
por: Zappe, Dion H., et al.
Publicado: (2015)

Overview of clinical use and side effect profile of valsartan in Chinese hypertensive patients
por: Huang, Qi-Fang, et al.
Publicado: (2013)

Silencing salusin-β attenuates cardiovascular remodeling and hypertension in spontaneously hypertensive rats
por: Ren, Xing-Sheng, et al.
Publicado: (2017)

Efficacy of amlodipine besylate and Valsartan for the treatment of mild to moderate hypertension
por: Wang, Xiao-ou, et al.
Publicado: (2019)

Addition of Amlodipine or Valsartan for Improvement of Diastolic Dysfunction Associated with Hypertension
por: Oh, Jin Kyung, et al.
Publicado: (2020)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
por: Aykan, Duygun Altintas, et al.
Publicado: (2020)

Sacubitril/Valsartan in the Treatment of Resistant Hypertension: Raising Star or Illusion?
por: Tadic, Marijana, et al.
Publicado: (2022)

Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension
por: Zhang, Yaling, et al.
Publicado: (2022)

Exploring the Food and Drug Administration’s review and approval of Entresto (sacubitril/valsartan)
por: Eadie, Ashley L., et al.
Publicado: (2021)

Emerging trends in sacubitril/valsartan research: A bibliometric analysis of the years 1995–2021
por: Lai, Ping, et al.
Publicado: (2022)

Effects of sacubitril-valsartan in patients undergoing maintenance dialysis
por: Ding, Ying, et al.
Publicado: (2023)

Effect of Gut Microbiota on the Pharmacokinetics of Nifedipine in Spontaneously Hypertensive Rats
por: Zhou, Rong, et al.
Publicado: (2023)

Role of gut microbiota on intestinal barrier function in acute pancreatitis
por: Li, Xue-Yang, et al.
Publicado: (2020)

Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System
por: Simko, Fedor, et al.
Publicado: (2022)

Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis
por: Yang, Pei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3in0rkor4jdhvm2b0pbsd5ekgg